{"id":"NCT01767116","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection","officialTitle":"A Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in Treatment-Naive Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection (PEARL-III)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12","primaryCompletion":"2013-12","completion":"2014-08","firstPosted":"2013-01-14","resultsPosted":"2015-01-06","lastUpdate":"2021-07-12"},"enrollment":419,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C Infection"],"interventions":[{"type":"DRUG","name":"ABT-450/r/ABT-267, ABT-333","otherNames":["ABT-267 also known as ombitasvir","ABT-450 also known as paritaprevir","ABT-333 also known as dasabuvir","Viekira PAK"]},{"type":"DRUG","name":"Ribavirin","otherNames":[]},{"type":"DRUG","name":"Placebo for ribavirin","otherNames":[]}],"arms":[{"label":"ABT-450/r/ABT-267 and ABT-333, Plus RBV","type":"EXPERIMENTAL"},{"label":"ABT-450/r/ABT-267 and ABT-333, Plus Placebo RBV","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and antiviral activity of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267; ABT-450 also known as paritaprevir; ABT-267 also known as ombitasvir) and ABT-333 (also known as dasabuvir) with and without ribavirin (RBV) in patients with chronic hepatitis C virus genotype 1b (HCV GT1b) infection without cirrhosis.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment; Noninferiority Analyses of Each Treatment Arm Compared to Historical Rate","timeFrame":"12 weeks after last dose of study drug","effectByArm":[{"arm":"ABT-450/r/ABT-267 and ABT-333, Plus RBV","deltaMin":99.5,"sd":null},{"arm":"ABT-450/r/ABT-267 and ABT-333, Plus Placebo RBV","deltaMin":100,"sd":null}],"pValues":[{"comp":"OG001","p":null},{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24795200","29377566"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":210},"commonTop":["HEADACHE","FATIGUE","PRURITUS","ASTHENIA","NAUSEA"]}}